Gene · 21
NIH grants938
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 938
Download this page as JSON| Grant | Title | ABCA3 papers | Newest fiscal year |
|---|---|---|---|
| P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 1 | 2024 |
| P30EY019007 | Core Facilities for Vision Research | 1 | 2024 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 1 | 2024 |
| R01AG066198 | Physical exercise and Blood-brain communication: exosomes, Klotho and choroid plexus | 1 | 2024 |
| R01AG067014 | Intestinal Stem Cell Function During Aging and Tumor Initiation | 1 | 2024 |
| R01AI110700 | Cell entry, cross-species transmission and pathogenesis of novel coronavirus from | 1 | 2024 |
| R01AI112844 | Molecular regulation of protective CD8 immunity against influenza infection | 1 | 2024 |
| R01AI153433 | A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines | 1 | 2024 |
| R01AI154598 | Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection | 1 | 2024 |
| R01AI155696 | Macrophage Polarization in Response to Infections and Inflammation | 1 | 2024 |
| R01AI157253 | Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross | 1 | 2024 |
| R01CA204120 | Novel Methods for Identifying Genetic Interactions for Cancer Prognosis | 1 | 2024 |
| R01DK090242 | Regulation of Peroxisomal Metabolism by Lysine Acylation | 1 | 2024 |
| R01DK121072 | Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte | 1 | 2024 |
| R01DK123049 | In utero gene editing to cure a metabolic liver disease | 1 | 2024 |
| R01GM139875 | Characterizing the physiological and pharmacological roles of SLC22A24 | 1 | 2024 |
| R01HL122596 | Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension | 1 | 2024 |
| R01HL127203 | The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary Fibrosis | 1 | 2024 |
| R01HL151397 | Development, Formulation and Inhalational Delivery of a New Peptide for ILD | 1 | 2024 |
| R01HL153248 | Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/grants?page=11